Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

This approval allows Bionpharma to commercialize the product in the United States, expanding patient access to a more ...

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...

Eltrombopag tablets are indicated for the treatment of thrombocytopenia (low platelet count) in specific blood disorders.

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.

Mind Medicine has altered its state, rebranding as Definium Therapeutics ahead of a series of phase 3 data drops on its lead ...

The "Canine Oral Chewable Tablets Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The canine oral chewable tablets market is evolving as pet owner ...

Bionpharma's etravirine tablet for HIV/AIDS, developed on a continuous manufacturing platform, got Abbreviated New Drug ...

TRS offers a robust solution for analyzing heterogeneous samples, providing comprehensive spectral data essential for ...